Press

HORSHAM, Pa. October 22, 2010 – Verilogue, a leading pharmaceutical market research firm that captures and analyzes authentic physician-patient interactions, will examine the current and future influence of EHR [Electronic Health Record] on the doctor-patient dialogue. Specifically, Verilogue’s case study presentation at the Pharmaceutical Market Research Group (PMRG) Institute in Boston later this month will…

HORSHAM, Pa. – October 8, 2010 – Following a period of rapid growth and commercial success in an overall sluggish economy, healthcare market research firm Verilogue donated a day of community service to welcome home Pennsylvania troops returning from tours overseas. Under the guidance of Normandy Farms’ experienced chefs, Verilogue team members prepared entrees and notes…

Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-science industry. This special issue, now its sixth year, has become a must-read and one of the…

HORSHAM, Pa. – June 29, 2010 – The first health care market research company to listen to, analyze and deliver nationwide insights derived from naturally-occurring dialogue between patients and physicians,Verilogue today announced it has captured more than 50,000 physician-patient conversations across the continuum of care, from routine well visits to the heartfelt delivery of metastatic…

The battle for the hearts, minds and prescription pads of physicians treating targeted patients has always been challenging, but competitive pressures have never been more intense. Impending patent expirations threaten to expose billions of dollars in branded products to generic erosion. Mounting regulatory pressures, feverish political climate and lukewarm economic conditions place even greater restrictions…

REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…

This past September, Med Ad News began its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are providing the most innovative and interesting products, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nominations, many of which were provided by our…

Just a few short years ago most doctors were technophobic. You would have been hard-pressed to get a physician to consider electronic prescribing or logging-on to web-based medical conference. What a difference a few years can make. According to Manhattan Research, in 2009 ,87% of US physicians are considered “ePharma” physicians. In others words, they…

In the upcoming November issue of Med Ad News, our sales-force effectiveness series continues with a technology round up, providing a catalogue of new and upgraded tech solutions for pharma sales forces. But technology is not only connecting healthcare professionals with pharmaceutical marketers. Physicians are connecting with their patients through digital channels as well. According…

It doesn’t take several years of post-graduate studies and a degree in medicine to describe what it’s like to live with a disease. From a patient’s perspective, the practical wisdom available in an embar-rassing anecdote, or a triumphant description of a breakthrough,can sometimes provide more value than any discussion to be had inside a doctor’s…